ARTICLE | Distillery Therapeutics
Therapeutics: Mesothelin; programmed cell death 1 (PD-1; PDCD1; CD279)
August 4, 2016 7:00 AM UTC
Mouse studies suggest chimeric antigen receptor (CAR) T cells engineered to express a dominant-negative variant of PD-1 could help treat mesothelioma. The CAR T cells were engineered to express a meso...